RECENT NEWS

The Government has accepted advice on eligibility from the Joint Committee on Vaccination and Immunisation (JCVI) for the spring 2026 COVID-19 vaccination programme.

New research has identified a way to predict resistance to a cancer drug commonly used to treat advanced prostate cancer.

BD (Becton, Dickinson and Company) has announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.

Molecular diagnostics firm Alveo Technologies has announced a strategic partnership with Global Animal Health (GAH) to introduce the Alveo Sense Poultry Avian Influenza Test at broad scale across Egypt.

A large-scale population study which included a pTau217 blood test has demonstrated the feasibility of deploying blood tests at scale in population-level research, supporting earlier detection and treatment eligibility assessment.

The Royal College of Pathologists has responded to The Health Foundation’s NHS Productivity Commission call for evidence, highlighting pathology’s central role in patient care and proposing four practical reforms to unlock efficiency and resilience.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a ‘call for evidence’, asking for views on how AI in healthcare should be regulated.

The 2026 edition of the Biomedical Science Industry Handbook is available to read online now.

ALZpath – which develops diagnostic tools for Alzheimer's disease and related dementias – has announced a licensing agreement with Siemens Healthineers for use of its proprietary pTau217 antibody in the development of a pTau217 assay.

BD (Becton, Dickinson and Company) has announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following IVDR certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX System.

A multinational workshop for strengthening disease surveillance in Africa has revealed the persistent antibiotic resistance of cholera-causing bacteria on the continent.

The National Institute for Health and Care Excellence (NICE) has announced Professor Jonathan Benger CBE as incoming Chief Executive, taking over from Dr Samantha Roberts.

Roche has secured CE Mark approval for its mass spectrometry reagent pack for antibiotics drug monitoring. This establishes Roche's in-vitro diagnostics (IVD) menu as the broadest available for any automated mass spectrometry platform, including already 39 of the most frequently tested targets.

A revolutionary quantum sensing project that could transform cancer treatment by tracking how immune cells interact with tumours has been awarded a prestigious £2 million Future Leaders Fellowship.

A new blood test can accurately identify different types of breast cancer – meaning patients can be matched to the correct treatment without the need for a biopsy.

Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respected regulators together with one of the world’s leading biotech creators.

Digital pathology firm PathAI has announced a new partnership with University Medical Center Utrecht, one of Europe’s leading academic medical centres, to deploy AISight Dx, PathAI’s digital pathology image management system, to accelerate the adoption of AI algorithms.

A human challenge trial supported by the National Institute for Health and Care Research (NIHR)has shown that a new vaccine could offer better protection against whooping cough.

The UK Health Security Agency (UKHSA) has identified a new recombinant mpox virus in England in an individual who had recently travelled to Asia.

South Korean molecular diagnostics firm Seegene has announced the establishment of a new subsidiary in France to reinforce its European presence and support global sales expansion.